Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,894 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp.
Castanheira M, Jones RN, Livermore DM. Castanheira M, et al. Diagn Microbiol Infect Dis. 2009 Apr;63(4):426-33. doi: 10.1016/j.diagmicrobio.2009.01.026. Epub 2009 Feb 26. Diagn Microbiol Infect Dis. 2009. PMID: 19249180
Assessment of 30/20-Microgram Disk Content versus MIC Results for Ceftazidime-Avibactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa.
Sader HS, Rhomberg PR, Huband MD, Critchley IA, Stone GG, Flamm RK, Jones RN. Sader HS, et al. J Clin Microbiol. 2018 May 25;56(6):e01960-17. doi: 10.1128/JCM.01960-17. Print 2018 Jun. J Clin Microbiol. 2018. PMID: 29563198 Free PMC article.
Activities of Tedizolid and Linezolid Determined by the Reference Broth Microdilution Method against 3,032 Gram-Positive Bacterial Isolates Collected in Asia-Pacific, Eastern Europe, and Latin American Countries in 2014.
Pfaller MA, Flamm RK, Jones RN, Farrell DJ, Mendes RE. Pfaller MA, et al. Antimicrob Agents Chemother. 2016 Aug 22;60(9):5393-9. doi: 10.1128/AAC.00881-16. Print 2016 Sep. Antimicrob Agents Chemother. 2016. PMID: 27353270 Free PMC article.
Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers.
Sader HS, Farrell DJ, Flamm RK, Jones RN. Sader HS, et al. Surg Infect (Larchmt). 2016 Aug;17(4):443-7. doi: 10.1089/sur.2015.209. Epub 2016 Mar 18. Surg Infect (Larchmt). 2016. PMID: 26990170 Clinical Trial.
Antimicrobial Activities of Ceftaroline and Comparator Agents against Bacterial Organisms Causing Bacteremia in Patients with Skin and Skin Structure Infections in U.S. Medical Centers, 2008 to 2014.
Sader HS, Flamm RK, Mendes RE, Farrell DJ, Jones RN. Sader HS, et al. Antimicrob Agents Chemother. 2016 Mar 25;60(4):2558-63. doi: 10.1128/AAC.02794-15. Print 2016 Apr. Antimicrob Agents Chemother. 2016. PMID: 26856825 Free PMC article.
Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia.
Sader HS, Castanheira M, Flamm RK, Mendes RE, Farrell DJ, Jones RN. Sader HS, et al. Int J Antimicrob Agents. 2015 Jul;46(1):53-9. doi: 10.1016/j.ijantimicag.2015.02.022. Epub 2015 Apr 14. Int J Antimicrob Agents. 2015. PMID: 25956844
Activity of oritavancin against Gram-positive clinical isolates responsible for documented skin and soft-tissue infections in European and US hospitals (2010-13).
Mendes RE, Farrell DJ, Sader HS, Flamm RK, Jones RN. Mendes RE, et al. J Antimicrob Chemother. 2015 Feb;70(2):498-504. doi: 10.1093/jac/dku421. Epub 2014 Oct 31. J Antimicrob Chemother. 2015. PMID: 25362568 Clinical Trial.
Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.
Mendes RE, Deshpande LM, Jones RN. Mendes RE, et al. Drug Resist Updat. 2014 Apr;17(1-2):1-12. doi: 10.1016/j.drup.2014.04.002. Epub 2014 Apr 6. Drug Resist Updat. 2014. PMID: 24880801 Review.
1,894 results
Jump to page